Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.2 (metadata) and no substantive study content changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-27T04:05:35.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The government funding/operating status banner was removed from the page. The study content and details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-19T22:07:56.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    No substantial changes detected in the Study Details page content, including the eligibility criteria, interventions, primary/secondary outcomes, or locations; any differences are limited to formatting or rendering. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-29T10:05:32.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and updated version to v3.2.0; removal of the prior v3.1.0 version tag.
    Difference
    3%
    Check dated 2025-10-07T23:12:25.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Version metadata updated from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T02:16:49.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page updates from Revision: v3.0.1 to v3.0.2; the 'Back to Top' navigation entry was removed. There are no substantive changes to core content, pricing, stock, or schedules.
    Difference
    0.2%
    Check dated 2025-09-14T18:52:59.000Z thumbnail image

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.